Skip to main content
. Author manuscript; available in PMC: 2020 Sep 15.
Published in final edited form as: Clin Cancer Res. 2019 Sep 23;25(24):7381–7387. doi: 10.1158/1078-0432.CCR-19-1658

Table 1.

Patient demographics

Total RECIST Only RECIST and PET PET Only
(n = 77) (n = 34) (n = 29) (n = 14)
Mean age, years (range) 60 (37–87) 59 (44–87) 60 (37–79) 62 (45–76)
Sex, n (%)
 Female 75 (97) 33 (97) 29 (100) 13 (93)
 Male 2 (3) 1 (3) 0 1 (7)
Race, n (%)
 White 68 (88) 29 (85) 25 (86) 14 (100)
 Asian 3 (4) 1 (3) 2 (7) 0
 Black/African American 3 (4) 3 (9) 0 0
 Other 2 (3) 0 2 (7) 0
 Unknown 1 (1) 1 (3) 0 0
Disease location at enrollment, n (%)
 Visceral tumor 57 (74) 29 (85) 26 (90) 2 (14)
 Bone metastasis 24 (31) 6 (18) 11 (38) 7 (50)
Median No. of prior therapies in metastatic setting (range) 3 (0–11) (0–9) 2 (0–11) 2 (0–7)
Median time from first metastasis to enrollment, years (range) 2.3 (0.1–11.5) 2.8 (0.3–11.5) 2.0 (0.2–10.8) 1.4 (0.1–3.6)

Abbreviations: PRC, PET Response Criteria; RECIST, Response Evaluation Criteria in Solid Tumors.